Jing Qiu

Dr. Qiu is an Associate at Oberland Capital. Previously, she was a Business Development Associate at Rejuveron Life Sciences focusing on the search and evaluation of early-stage assets in the longevity space. Previously, Dr. Qiu was a Senior Consultant at ClearView Healthcare Partners where she provided strategic insights to biotech and pharmaceutical companies. Dr. Qiu completed a Ph.D. at Yale University in Genetics focusing on the link between cell cycle control and cell fate decision. Dr. Qiu was a Venture Fellow for Canaan Partners and F-Prime Capital during her graduate work. She also holds a B.S. from the University of Virginia in Biology and Studio Art.